Massachusetts Institute of Technology
Department of Biology Headquarters, Building 68-13
77 Massachusetts Avenue
Cambridge
Massachusetts
02139-4307
United States
Tel: 617-253-4701
Fax: 617-253-8699
Website: http://www.mit.edu/
Email: mitbiohq@mit.edu
About Massachusetts Institute of Technology
The mission of MIT is to advance knowledge and educate students in science, technology and other areas of scholarship that will best serve the nation and the world in the 21st century.
The Institute is committed to generating, disseminating and preserving knowledge, and to working with others to bring this knowledge to bear on the world's great challenges. MIT is dedicated to providing its students with an education that combines rigorous academic study and the excitement of discovery with the support and intellectual stimulation of a diverse campus community. We seek to develop in each member of the MIT community the ability and passion to work wisely, creatively and effectively for the betterment of humankind.
697 articles about Massachusetts Institute of Technology
-
Artificial intelligence identifies anti-aging drug candidates targeting ‘zombie’ cells
5/4/2023
Integrated Biosciences in collaboration with researchers at the Massachusetts Institute of Technology and the Broad Institute of MIT and Harvard, announced results demonstrating the power of artificial intelligence to discover novel senolytic compounds, a class of small molecules under intense study for their ability to suppress age-related processes such as fibrosis, inflammation and cancer.
-
Horizon Therapeutics plc and Massachusetts Institute of Technology (MIT) Solve Announce the Launch of the Third Annual Horizon Prize to Inspire Sustainable Solutions for Research and Care in the Rare Disease Community
4/18/2023
Horizon Therapeutics plc announced the launch of the third annual global innovation challenge, The Horizon Prize, powered by MIT Solve.
-
Philips and MIT IMES develop enhanced critical care data set to give researchers and educators access to advance clinical understanding and AI in healthcare
4/18/2023
Royal Philips announced an expansion of its initiative with the Institute for Medical Engineering and Science at the Massachusetts Institute of Technology to allow health care researchers access to a new critical care data set to help advance machine learning and artificial intelligence in healthcare.
-
Newly-launched Massachusetts biomanufacturing facility will be something like a conveyor belt from the academic bench to the early startup. -
If established as safe and effective in humans, this technology could prove transformative in treating many diseases, such as diabetes. -
Neuro News: Acadia Receives CRL, Sosei and Microglia Advance Schizophrenia Treatment & More
8/5/2022
This week's highlights in neurological diseases include Acadia receiving a CRL for its ADP drug, Sosei and Neurocrine's schizophrenia drug study moving on to Phase II. -
Once proven clinically safe and effective, MIT's technology could pave the way toward “self-boosting” vaccines and eliminate the need for multiple shots. -
From search engines to social media, algorithms are quickly becoming a part of everyday life, and companies like Bayer, MIT and others are using them to their advantage. -
New research by investigators at Columbia University and MIT describes how cancer cells often depend upon the importation of fat for continued growth and division. -
Researchers from all around the world have been working on mapping human genes to their functions. Now, for the first time, that mapping has been completed. -
Elicio Therapeutics published data on the preprint server bioRxiv, describing preclinical research into its cancer vaccine that shows a lot of promise. -
A study by researchers at the Massachusetts Institute of Technolog (MIT) have found a brain circuit in the anterior thalamus that is critical for memory function. -
David Sabatini has withdrawn his name for consideration for a faculty post at New York University Langone Health. -
With $67 million in Series A financing, newly-launched Apertura plans to develop genetic medicines using technologies that address key limitations of gene delivery and expression. -
Research Roundup: COVID-19 Pneumonia and Dementia Risk, Prostate Cancer Advances - and Oreos
4/22/2022
COVID-19 continues to generate surprises, such as a possible link between dementia and severe COVID-19. Continue reading for that and more research stories. -
Horizon Therapeutics and Massachusetts Institute of Technology (MIT) Solve Announce Second Annual Horizon Prize to Inspire Solutions that Improve the Quality of Life for the Global Rare Disease Community
4/19/2022
Horizon Therapeutics plc announced the kickoff of the second annual global innovation challenge, The Horizon Prize powered by MIT Solve.
-
Galen Robotics will further benefit from Robert Langer’s extensive experience in biotech startups and hands-on laboratory work. -
David Sabatini's resignation follows a decision from three senior MIT officers that recommended his tenure's revocation.
-
Ishtiaq Ali Saaem is sentenced to three years of probation following a guilty plea to charges he obstructed a federal investigation into his efforts to acquire the deadly toxin ricin. -
The U.S. Patent and Trademark Office ruled that the use of CRISPR-Cas9 in humans belongs to Broad, not UC Berkeley.